PDF) Promotion of natural tooth repair by small molecule GSK3 antagonists
GSK3 Inhibitor-Induced Dentinogenesis Using a Hydrogel - A. Alaohali, C. Salzlechner, L.K. Zaugg, F. Suzano, A. Martinez, E. Gentleman, P.T. Sharpe, 2022
PDF) Tideglusib, a GSK-3 inhibitor, reduces progression of brain atrophy in progressive supranuclear palsy
Can Teeth Repair Themselves Without Fillings | Community Healthcare System
Tideglusib enhances odontogenic differentiation in human dental pulp stem cells in vitro - Kornsuthisopon - 2023 - International Endodontic Journal - Wiley Online Library
Tideglusib - Wikipedia
Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β | SpringerLink
Materials | Free Full-Text | Evaluating the Effect of Tideglusib-Loaded Bioactive Glass Nanoparticles as a Potential Dentine Regenerative Material
Therapeutic: tideglusib for congenital myotonic dystrophy
Tideglusib for Myotonic Dystrophy Clinical Trial 2023 | Power
Vijai Dental Depot Chennai - Researchers at King's College London have identified that Tideglusib can regenerate teeth from the inside out, possibly reducing the need for artificial fillings. The drug was previously
Frontiers | GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis
IJMS | Free Full-Text | Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
In vitro evaluation of injectable Tideglusib-loaded hyaluronic acid hydrogels incorporated with Rg1-loaded chitosan microspheres for vital pulp regeneration - ScienceDirect
Decline of the dentist's drill? Drug helps rotten teeth regenerate, trial shows | Stem cells | The Guardian
Promotion of natural tooth repair by small molecule GSK3 antagonists | Scientific Reports
FT30356 | 865854-05-3 | Tideglusib | Biosynth
Tideglusib = 98 HPLC 865854-05-3
Tideglusib | ≥99%(HPLC) | GSK-3 Inhibitor | AdooQ®
The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells | SpringerLink
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy - Tolosa - 2014 - Movement Disorders - Wiley Online Library
Apexbio Technology LLC Tideglusib, 10mg. Cas: 865854-05-3 MFCD: MFCD18633296. | Fisher Scientific
Promotion of natural tooth repair by small molecule GSK3 antagonists | Scientific Reports
